| 1 | [SID24811360] | Active | Potency | 3.1623 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504848, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504848 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID24811360] | Active | Potency | 3.5481 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 3 | [SID24811360] | Active | IC50 | 4.065 | Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor [AID463214, Type: confirmatory] | type-1 angiotensin II receptor [Homo sapiens] [gi:4501997] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 4.065 [uM] | | BioAssay | Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor | | AID | 463214 | | BioAssay type | confirmatory | | Target | type-1 angiotensin II receptor [Homo sapiens] [gi:4501997] | | PubMed | | | Data Table |  |
|
| 4 | [SID24811360] | Active | IC50 | 4.065 | Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor [AID463214, Type: confirmatory] | type-1 angiotensin II receptor [Homo sapiens] [gi:4501997] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 4.065 [uM] | | BioAssay | Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor | | AID | 463214 | | BioAssay type | confirmatory | | Target | type-1 angiotensin II receptor [Homo sapiens] [gi:4501997] | | PubMed | | | Data Table |  |
|
| 5 | [SID24811360] | Active | Potency | 4.4668 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 6 | [SID24811360] | Active | Potency | 4.4668 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 7 | [SID24811360] | Active | Potency | 4.4668 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 8 | [SID24811360] | Active | IC50 | 4.93 | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 4.93 [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 9 | [SID24811360] | Active | IC50 | 4.93 | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 4.93 [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 10 | [SID24811360] | Active | IC50 | 4.93 | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 4.93 [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 11 | [SID24811360] | Active | IC50 | 4.93 | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 4.93 [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 12 | [SID24811360] | Active | AC50 | 6.535 | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set2 [AID493177, Type: confirmatory] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | AC50 | 6.535 [uM] | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set2 | | AID | 493177 | | BioAssay type | confirmatory | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 13 | [SID24811360] | Active | AC50 | 6.535 | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set2 [AID493177, Type: confirmatory] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | AC50 | 6.535 [uM] | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set2 | | AID | 493177 | | BioAssay type | confirmatory | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 14 | [SID24811360] | Active | AC50 | 6.535 | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set4 [AID493102, Type: confirmatory] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | AC50 | 6.535 [uM] | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set4 | | AID | 493102 | | BioAssay type | confirmatory | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 15 | [SID24811360] | Active | AC50 | 6.535 | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set4 [AID493102, Type: confirmatory] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | AC50 | 6.535 [uM] | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set4 | | AID | 493102 | | BioAssay type | confirmatory | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 16 | [SID24811360] | Active | AC50 | 6.535 | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set3 [AID493073, Type: confirmatory] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | AC50 | 6.535 [uM] | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set3 | | AID | 493073 | | BioAssay type | confirmatory | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 17 | [SID24811360] | Active | AC50 | 6.535 | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set3 [AID493073, Type: confirmatory] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | AC50 | 6.535 [uM] | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set3 | | AID | 493073 | | BioAssay type | confirmatory | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 18 | [SID24811360] | Active | IC50 | 9.72 | Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2784, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 9.72 [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2784 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 19 | [SID24811360] | Active | IC50 | 9.72 | Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2784, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 9.72 [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2784 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 20 | [SID24811360] | Active | Potency | 9.9763 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 9.9763 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 21 | [SID24811360] | Active | IC50 | 9.98 | Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis [AID488890, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 9.98 [uM] | | BioAssay | Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis | | AID | 488890 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID24811360] | Active | Potency | 10 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504850, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504850 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID24811360] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 24 | [SID24811360] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 25 | [SID24811360] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 26 | [SID24811360] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition [AID2785, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Giardia lamblia growth inhibition | | AID | 2785 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 27 | [SID24811360] | Active | IC50 | 40.2 | A Cell Based Secondary Assay to Explore Compounds that Modulate Non-Replicating, Drug-tolerant Compounds in Replicating H37Rv TB of Mycobacterium tuberculosis [AID492952, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | IC50 | 40.2 [uM] | | BioAssay | A Cell Based Secondary Assay to Explore Compounds that Modulate Non-Replicating, Drug-tolerant Compounds in Replicating H37Rv TB of Mycobacterium tuberculosis | | AID | 492952 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID24811360] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 29 | [SID24811360] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 30 | [SID24811360] | Active | | | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay [AID493098, Type: screening] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay | | AID | 493098 | | BioAssay type | screening | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 31 | [SID24811360] | Active | | | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay [AID493098, Type: screening] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay | | AID | 493098 | | BioAssay type | screening | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 32 | [SID24811360] | Active | | | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2521, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2521 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 33 | [SID24811360] | Active | | | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2521, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2521 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 34 | [SID24811360] | Active | | | Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2766, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2766 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 35 | [SID24811360] | Active | | | Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2766, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2766 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 36 | [SID24811360] | Active | | | Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID492964, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 492964 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 37 | [SID24811360] | Active | | | Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID492964, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 492964 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 38 | [SID24811360] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 39 | [SID24811360] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 40 | [SID24811360] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 41 | [SID24811360] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 42 | [SID24811360] | Active | | | Primary cell-based high throughput screening assay to measure STAT1 activation [AID932, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 activation | | AID | 932 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 43 | [SID24811360] | Active | | | Primary cell-based high throughput screening assay to measure STAT1 activation [AID932, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 activation | | AID | 932 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 44 | [SID24811360] | Active | | | Counterscreen for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogenous time resolved fluorescence (HTRF)-based cell-based assay to identify antagonists of the parental CHO-K1 cell line [AID493232, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Counterscreen for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogenous time resolved fluorescence (HTRF)-based cell-based assay to identify antagonists of the parental CHO-K1 cell line | | AID | 493232 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID24811360] | Active | | | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID449763, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 449763 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID24811360] | Active | | | Single concentration confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID463112, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 463112 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID24811360] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID24811360] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID24811360] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 50 | [SID24811360] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24811360 | | CID | 46495021 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|